Inventor · disambiguated record
Leo Pavliv
Also filed as: PAVLIV LEO
40 granted patents·54 pending applications·253 citations·filing 1988–2025
98Inventor score
Files withCUMBERLAND PHARMACEUTICALS INC64PAVLIV LEO12CUMBERLAND PHARMACEUTICALS4UNIV VANDERBILT3COFFEY MATTHEW C2
Top patents by PatentIndex Score
94 records- 0194US8952065B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Feb 10, 2015·16 cites·9 claims
- 0294US8653061B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2014·17 cites·10 claims
- 0394US8399445B2Acetylcysteine composition and uses thereofPAVLIV LEO·Filed 2012·Granted Mar 19, 2013·17 cites·16 claims
- 0494US8148356B2Acetylcysteine composition and uses thereforPAVLIV LEO·Filed 2005·Granted Apr 3, 2012·22 cites·14 claims
- 0594US4929739AComplexes of tellurium and selenium derivativesUNIV BAR ILAN·Filed 1988·Granted May 29, 1990·41 cites·17 claims
- 0693US8722738B2Acetycysteine compositions and methods of use thereofPAVLIV LEO·Filed 2011·Granted May 13, 2014·18 cites·21 claims
- 0793US7605123B2Fatty acid formulations for oral delivery of proteins and peptides, and uses thereofBIOCON LTD·Filed 2005·Granted Oct 20, 2009·25 cites·15 claims
- 0891US9327028B2Acetylcysteine compositions and methods of use thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·12 cites·11 claims
- 0991US6727286B2Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acidCUMBERLAND PHARMACEUTICALS INC·Filed 2001·Granted Apr 27, 2004·31 cites·44 claims
- 1090US11806400B2Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Nov 7, 2023·2 cites·16 claims
- 1188US2025114334A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1286US9045728B2Liquid viral formulationsCOFFEY MATTHEW C·Filed 2011·Granted Jun 2, 2015·10 cites·35 claims
- 1385US9693998B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·4 cites·20 claims
- 1484US2024024481A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1584US2023381147A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1683US9610309B2Liquid viral formulationsONCOLYTICS BIOTECH INC·Filed 2015·Granted Apr 4, 2017·4 cites·32 claims
- 1782US9114068B2Treating patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·2 cites·14 claims
- 1880US9610352B2Lyophilized viral formulationsONCOLYTICS BIOTECH INC·Filed 2015·Granted Apr 4, 2017·3 cites·34 claims
- 1980US9072710B2Injectable ibuprofen formulationPAVLIV LEO·Filed 2012·Granted Jul 7, 2015·3 cites·37 claims
- 2079US9044498B2Lyophilized viral formulationsCOFFEY MATTHEW C·Filed 2011·Granted Jun 2, 2015·4 cites·37 claims
- 2178US12161632B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 2278US11571412B2Thromboxane receptor antagonists in AERD/asthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Feb 7, 2023·0 cites·4 claims
- 2378US10314824B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·1 cites·9 claims
- 2478US10064845B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·2 cites·22 claims
- 2577US9072661B2Injectable ibuprofen formulationPAVLIV LEO·Filed 2012·Granted Jul 7, 2015·4 cites·28 claims
- 2677US8778907B2Lactulose for bowel evacuationPAVLIV LEO·Filed 2011·Granted Jul 15, 2014·1 cites·38 claims
- 2777US2022133696A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2877US2020121793A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2976US9931311B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Apr 3, 2018·1 cites·7 claims
- 3076US9012508B2Administration of intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted Apr 21, 2015·2 cites·5 claims
- 3176US8735452B2Treating patients with intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted May 27, 2014·1 cites·16 claims
- 3276US2025049764A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3376US2022211674A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3476US2022218672A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3575US8871810B2Treating critically ill patients with intravenous ibuprofenPAVLIV LEO·Filed 2009·Granted Oct 28, 2014·1 cites·13 claims
- 3674US8933115B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·1 cites·27 claims
- 3774US8563685B2Fatty acid formulations and oral delivery of proteins and peptides, and uses thereofRADHAKRISHNAN BALASINGAM·Filed 2009·Granted Oct 22, 2013·1 cites·12 claims
- 3874US2020375953A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3973US9649284B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted May 16, 2017·1 cites·19 claims
- 4073US9138404B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·1 cites·20 claims
- 4173US2021137895A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4273US2025235539A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4373US2021106561A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4472US10925860B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Feb 23, 2021·0 cites·7 claims
- 4572US9295639B2Treating critically ill patients with intravenous ibuprofenPAVLIV LEO·Filed 2010·Granted Mar 29, 2016·1 cites·16 claims
- 4672US2020316022A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4771US2021015798A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4871US2020171007A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4970US2020253935A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 5069US10583126B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·0 cites·7 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Leo Pavliv files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →